Patient and Family Decision Making in the Palliative Care Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00682994|
Recruitment Status : Completed
First Posted : May 23, 2008
Last Update Posted : February 19, 2016
The goal of this research study is to learn about any differences in certain health-related preferences between patients with cancer and their families.
The main preferences being studied are how decisions are made about healthcare, as well as how much information people want to know about cancer.
Specifically, researchers will compare questionnaire and interview data from Hispanic-Americans living in the United States (the M. D. Anderson part of this multicenter study) with Hispanics living in Latin America (in particular, Argentina, Chile, and Guatemala).
|Condition or disease||Intervention/treatment||Phase|
|Advanced Cancer||Behavioral: Interview Behavioral: Questionnaire||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||780 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Patient and Family Decision Making and Information Disclosure Preferences in the Palliative Care Setting: a Multi-Center Survey in Chile, Guatemala, and U.S.|
|Study Start Date :||March 2008|
|Actual Primary Completion Date :||August 2012|
|Actual Study Completion Date :||August 2012|
Questionnaire + Interview
Interview lasting about 5-10 minutes.Behavioral: Questionnaire
Questionnaires taking 20-30 minutes to complete.
Other Name: Survey
- Differences in Proportions of Preference for Passive Decision Making [ Time Frame: 6 Years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00682994
|United States, Texas|
|UT MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Fundacion FEMEBA - Programa Argentino de Medicina Paliativa - Hospital Tornu|
|Buenos Aires, Argentina|
|Dr. Sotero del Rio Hospital - Catholic University of Chile|
|Santiago, Chile, 8207257|
|Guatemalan Cancer Institute - INCAN|
|Guatemala City, Guatemala|
|Principal Investigator:||Eduardo Bruera, MD||M.D. Anderson Cancer Center|